Key result
The aminoglycoside antibiotic neomycin enhances the quantification and plaque formation of coxsackievirus in cultured cells in the absence of bacteria.
Why the study?
While intestinal bacteria promote enteric virus infections, whether antibiotics exert microbiota-independent effects on viruses remained possible.
Neomycin has microbiota-independent effects on coxsackievirus, enhancing its plaque formation in cultured cells.
Neomycin may artifactually boost coxsackievirus titers in cell culture; leaves open in vivo relevance.
Coxsackieviruses primarily infect the gastrointestinal tract of humans, but they can disseminate systemically and cause severe disease. Using antibiotic treatment regimens to deplete intestinal microbes in mice, several groups have shown the bacteria promote infection with a variety of enteric viruses. However, it is possible that antibiotics have microbiota-independent effects on viruses. Here we show that an aminoglycoside antibiotic, neomycin, can influence quantification of coxsackievirus in cultured cells in the absence of bacteria.
No takes yet. Share an insight, caveat, or question.
Acevedo et al. (2019) studied Coxsackievirus infection. Neomycin was evaluated on Coxsackievirus plaque formation in cultured cells. The aminoglycoside antibiotic neomycin enhances the quantification and plaque formation of coxsackievirus in cultured cells in the absence of bacteria.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: